Stage
No active trials
Next date
None yet
Trials
0 active
3 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “IV injection of IS-001 drug substance with near infrared (NIR) imaging”In the company’s words, NCT05954767 on ClinicalTrials.gov
- Tested for
- Ureter Injury (3 trials)
- Main trialPhase 3
- “This study evaluates the safety and efficacy of intravenous injection of IS-001 to aid in intraoperative ureter structure delineation.”In the company’s words, NCT05954767 on ClinicalTrials.gov
Other drugs for Ureter Injury
- LY4101174Eli Lilly · Phase 1
- LY4052031Eli Lilly · Phase 1
- VepugratinibEli Lilly · Phase 1
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials3
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Completed | 31 Jan 2025 | IS-001 Injection in Patients Undergoing Robotic-Assisted Gynecological Surgery | |
| Phase 2Completed | 8 Jul 2021 | A Safety and Efficacy Study of IS-001 Injection in Patients Undergoing Robotic Hysterectomy | |
| Phase 2Completed | 18 Mar 2024 | A Safety and Feasibility Study of IS-001 Injection in Patients Undergoing Robotic Colorectal Surgery |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026